 | • レポートコード：MRC23Q36064 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、84ページ • 納品方法：Eメール（2-3日） • 産業分類：医療 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のhERGスクリーニング市場について調査・分析し、世界のhERGスクリーニング市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（遺伝子型KCNH2、変異型KCNH2）、用途別セグメント分析（抗不整脈薬、抗精神病薬、抗生物質、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Charles River Laboratories、Eurofins Scientific、Merck KGaA、Cyprotex Limited、BSYS GmbH、Creative bioarray、Metrion biosciences、Aurora Biomedなどが含まれています。 世界のhERGスクリーニング市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、hERGスクリーニング市場規模を推定する際に考慮しました。本レポートは、hERGスクリーニングの世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、hERGスクリーニングに関するビジネス上の意思決定に役立てることを目的としています。 ・hERGスクリーニング市場の概要 - hERGスクリーニングのタイプ別セグメント - 世界のhERGスクリーニング市場規模：タイプ別分析（遺伝子型KCNH2、変異型KCNH2） - hERGスクリーニングの用途別セグメント - 世界のhERGスクリーニング市場規模：用途別分析（抗不整脈薬、抗精神病薬、抗生物質、その他） - 世界のhERGスクリーニング市場規模予測（2018年-2029年） ・hERGスクリーニング市場の成長トレンド - hERGスクリーニングの地域別市場規模（2018年-2029年） - hERGスクリーニング市場ダイナミクス - hERGスクリーニングの業界動向 - hERGスクリーニング市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：遺伝子型KCNH2、変異型KCNH2 - 世界のhERGスクリーニングのタイプ別市場規模（2018年-2023年） - 世界のhERGスクリーニングのタイプ別市場規模（2024年-2029年） ・用途別セグメント：抗不整脈薬、抗精神病薬、抗生物質、その他 - 世界のhERGスクリーニングの用途別市場規模（2018年-2023年） - 世界のhERGスクリーニングの用途別市場規模（2024年-2029年） ・hERGスクリーニングの地域別市場規模 - 北米のhERGスクリーニング市場規模（2018年-2029年） - アメリカのhERGスクリーニング市場規模（2018年-2029年） - ヨーロッパのhERGスクリーニング市場規模（2018年-2029年） - アジア太平洋のhERGスクリーニング市場規模（2018年-2029年） - 中国のhERGスクリーニング市場規模（2018年-2029年） - 日本のhERGスクリーニング市場規模（2018年-2029年） - 韓国のhERGスクリーニング市場規模（2018年-2029年） - インドのhERGスクリーニング市場規模（2018年-2029年） - オーストラリアのhERGスクリーニング市場規模（2018年-2029年） - 中南米のhERGスクリーニング市場規模（2018年-2029年） - 中東・アフリカのhERGスクリーニング市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Charles River Laboratories、Eurofins Scientific、Merck KGaA、Cyprotex Limited、BSYS GmbH、Creative bioarray、Metrion biosciences、Aurora Biomed ・アナリストの観点/結論 ・調査方法とデータソース |
HERG screening has been an important component of cardiac safety-pharmacology from the past many years. hERG was identified as a potassium-selective cardiac ion channel, Kv11.1, which plays an important role during cardiac repolarization.
Highlights
The global hERG Screening market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for hERG Screening is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for hERG Screening is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for hERG Screening in Antiarrhythmic is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of hERG Screening include Charles River Laboratories, Eurofins Scientific, Merck KGaA, Cyprotex Limited, BSYS GmbH, Creative bioarray, Metrion biosciences and Aurora Biomed, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for hERG Screening, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding hERG Screening.
The hERG Screening market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global hERG Screening market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the hERG Screening companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Charles River Laboratories
Eurofins Scientific
Merck KGaA
Cyprotex Limited
BSYS GmbH
Creative bioarray
Metrion biosciences
Aurora Biomed
Segment by Type
Gene KCNH2
Mutant KCNH2
Segment by Application
Antiarrhythmic
Antipsychotic
Antibiotics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of hERG Screening companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global hERG Screening Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Gene KCNH2
1.2.3 Mutant KCNH2
1.3 Market by Application
1.3.1 Global hERG Screening Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Antiarrhythmic
1.3.3 Antipsychotic
1.3.4 Antibiotics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global hERG Screening Market Perspective (2018-2029)
2.2 hERG Screening Growth Trends by Region
2.2.1 Global hERG Screening Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 hERG Screening Historic Market Size by Region (2018-2023)
2.2.3 hERG Screening Forecasted Market Size by Region (2024-2029)
2.3 hERG Screening Market Dynamics
2.3.1 hERG Screening Industry Trends
2.3.2 hERG Screening Market Drivers
2.3.3 hERG Screening Market Challenges
2.3.4 hERG Screening Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top hERG Screening Players by Revenue
3.1.1 Global Top hERG Screening Players by Revenue (2018-2023)
3.1.2 Global hERG Screening Revenue Market Share by Players (2018-2023)
3.2 Global hERG Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by hERG Screening Revenue
3.4 Global hERG Screening Market Concentration Ratio
3.4.1 Global hERG Screening Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by hERG Screening Revenue in 2022
3.5 hERG Screening Key Players Head office and Area Served
3.6 Key Players hERG Screening Product Solution and Service
3.7 Date of Enter into hERG Screening Market
3.8 Mergers & Acquisitions, Expansion Plans
4 hERG Screening Breakdown Data by Type
4.1 Global hERG Screening Historic Market Size by Type (2018-2023)
4.2 Global hERG Screening Forecasted Market Size by Type (2024-2029)
5 hERG Screening Breakdown Data by Application
5.1 Global hERG Screening Historic Market Size by Application (2018-2023)
5.2 Global hERG Screening Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America hERG Screening Market Size (2018-2029)
6.2 North America hERG Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America hERG Screening Market Size by Country (2018-2023)
6.4 North America hERG Screening Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe hERG Screening Market Size (2018-2029)
7.2 Europe hERG Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe hERG Screening Market Size by Country (2018-2023)
7.4 Europe hERG Screening Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific hERG Screening Market Size (2018-2029)
8.2 Asia-Pacific hERG Screening Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific hERG Screening Market Size by Region (2018-2023)
8.4 Asia-Pacific hERG Screening Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America hERG Screening Market Size (2018-2029)
9.2 Latin America hERG Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America hERG Screening Market Size by Country (2018-2023)
9.4 Latin America hERG Screening Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa hERG Screening Market Size (2018-2029)
10.2 Middle East & Africa hERG Screening Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa hERG Screening Market Size by Country (2018-2023)
10.4 Middle East & Africa hERG Screening Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River Laboratories
11.1.1 Charles River Laboratories Company Detail
11.1.2 Charles River Laboratories Business Overview
11.1.3 Charles River Laboratories hERG Screening Introduction
11.1.4 Charles River Laboratories Revenue in hERG Screening Business (2018-2023)
11.1.5 Charles River Laboratories Recent Development
11.2 Eurofins Scientific
11.2.1 Eurofins Scientific Company Detail
11.2.2 Eurofins Scientific Business Overview
11.2.3 Eurofins Scientific hERG Screening Introduction
11.2.4 Eurofins Scientific Revenue in hERG Screening Business (2018-2023)
11.2.5 Eurofins Scientific Recent Development
11.3 Merck KGaA
11.3.1 Merck KGaA Company Detail
11.3.2 Merck KGaA Business Overview
11.3.3 Merck KGaA hERG Screening Introduction
11.3.4 Merck KGaA Revenue in hERG Screening Business (2018-2023)
11.3.5 Merck KGaA Recent Development
11.4 Cyprotex Limited
11.4.1 Cyprotex Limited Company Detail
11.4.2 Cyprotex Limited Business Overview
11.4.3 Cyprotex Limited hERG Screening Introduction
11.4.4 Cyprotex Limited Revenue in hERG Screening Business (2018-2023)
11.4.5 Cyprotex Limited Recent Development
11.5 BSYS GmbH
11.5.1 BSYS GmbH Company Detail
11.5.2 BSYS GmbH Business Overview
11.5.3 BSYS GmbH hERG Screening Introduction
11.5.4 BSYS GmbH Revenue in hERG Screening Business (2018-2023)
11.5.5 BSYS GmbH Recent Development
11.6 Creative bioarray
11.6.1 Creative bioarray Company Detail
11.6.2 Creative bioarray Business Overview
11.6.3 Creative bioarray hERG Screening Introduction
11.6.4 Creative bioarray Revenue in hERG Screening Business (2018-2023)
11.6.5 Creative bioarray Recent Development
11.7 Metrion biosciences
11.7.1 Metrion biosciences Company Detail
11.7.2 Metrion biosciences Business Overview
11.7.3 Metrion biosciences hERG Screening Introduction
11.7.4 Metrion biosciences Revenue in hERG Screening Business (2018-2023)
11.7.5 Metrion biosciences Recent Development
11.8 Aurora Biomed
11.8.1 Aurora Biomed Company Detail
11.8.2 Aurora Biomed Business Overview
11.8.3 Aurora Biomed hERG Screening Introduction
11.8.4 Aurora Biomed Revenue in hERG Screening Business (2018-2023)
11.8.5 Aurora Biomed Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details